MILLIPLEX® Multiplex Assays for Cancer Biomarker Detection using Luminex® Technology

 

Biomarker detection multiplex assays for cancer research

Measure biomarkers in your cancer research with MILLIPLEX® multiplex assays. For the full listing, download our Analyte Quarterly brochure.

A tumor marker, or “biomarker,” is a molecular entity whose relative quantity or localization is different between tumor-bearing and non-tumor-bearing subjects. Understanding what are cancer biomarkers and their detection is important — not only for therapeutic use, but also because they can be used to decipher the signaling pathways underlying both normal and diseased cellular processes. Multiplexed detection of circulating cancer markers can accelerate studies of normal homeostasis and tumorigenic processes. Our wide ranging cancer panel offering includes kits to measure cancer biomarkers, checkpoint proteins, as well as cytokines, chemokines, and growth factors.

Based on Luminex® xMAP® technology, our multiplex cancer assays enable precise, multiparametric analysis of diseases and underlying processes.

Our analytically verified MILLIPLEX® assay kits provide:

  • Standards verified to match reference lots
  • Serum matrix for generating standard curves that accurately simulate conditions of native analyte conditions in serum or plasma
  • In-assay kit controls
  • Detection antibody cocktails to ensure consistent performance regardless of plex size
Popular Analytes*
Immune Checkpoint Proteins Circulating Tumor Markers Angiogenesis Metastasis
CTLA-4
PD-1
PD-L1
PD-L2
TIM-3
CA125
CEA
CA19-9
CA15-3
CYFRA21-1
Angiopoietin-2
suPAR
Thrombospondin-2
VEGF-C
VEGF-D
DKK1
GDF-15
Osteoprotegrin
Periostin
YKL40
*Only selected analytes listed